DermTech, Inc. Quarterly Operating Income (Loss) in USD from Q2 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
DermTech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q1 2024.
  • DermTech, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$20.5M, a 36% increase year-over-year.
  • DermTech, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$92.2M, a 23.2% increase year-over-year.
  • DermTech, Inc. annual Operating Income (Loss) for 2023 was -$104M, a 12.2% increase from 2022.
  • DermTech, Inc. annual Operating Income (Loss) for 2022 was -$118M, a 52.7% decline from 2021.
  • DermTech, Inc. annual Operating Income (Loss) for 2021 was -$77.4M, a 119% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$92.2M -$20.5M +$11.5M +36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$104M -$19.8M +$9.13M +31.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$113M -$19.8M +$9.45M +32.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$122M -$32.1M -$2.3M -7.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$120M -$32M -$1.85M -6.14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$118M -$28.9M -$2.52M -9.56% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$116M -$29.3M -$8.94M -44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$107M -$29.8M -$12.5M -72.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$94.2M -$30.2M -$16.8M -125% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$77.4M -$26.4M -$16.9M -179% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$60.5M -$20.3M -$10.9M -116% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$49.6M -$17.3M -$7.88M -83.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$41.7M -$13.4M -$6.41M -91.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$35.3M -$9.46M -$4.35M -85% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$30.9M -$9.4M -$3.24M -52.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$27.7M -$9.43M -$6.1M -183% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$21.6M -$7M -$4M -133% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$17.6M -$5.12M -$4.78M -1444% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$12.8M -$6.16M -$4.05M -192% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$8.77M -$3.33M -$3.17M -2004% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$5.6M -$3M -$2.92M -3573% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$2.68M -$331K -$234K -240% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-14
Q3 2018 -$2.45M -$2.11M -$2.01M -1916% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$442K -$158K -$136K -602% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$306K -$81.8K Jan 1, 2018 Mar 31, 2018 10-K 2019-06-14
Q4 2017 -$97.3K -$97.3K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$105K -$105K -348693% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$22.5K -$22.5K -74983% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q4 2016 $0 Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 -$30* Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$30* Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.